Literature DB >> 25089635

Treatment and follow-up strategies in desmoid tumours: a practice guideline.

M Ghert1, X Yao2, T Corbett3, A A Gupta4, R A Kandel5, S Verma6, J Werier7.   

Abstract

OBJECTIVES: We set out to determine the optimal treatment options-surgery, radiation therapy (rt), systemic therapy, or any combinations thereof-for patients with desmoid tumours once the decision to undergo active treatment has been made (that is, monitoring and observation have been determined to be inadequate).provide clinical-expert consensus opinions on follow-up strategies in patients with desmoid tumours after primary interventional management.
METHODS: This guideline was developed by Cancer Care Ontario's Program in Evidence-Based Care and the Sarcoma Disease Site Group. The medline, embase, and Cochrane Library databases, main guideline Web sites, and abstracts of relevant annual meetings (1990 to September 2012) were searched. Internal and external reviews were conducted, with final approval by the Program in Evidence-Based Care and the Sarcoma Disease Site Group. RECOMMENDATIONS TREATMENTS: Surgery with or without rt can be a reasonable treatment option for patients with desmoid tumours whose surgical morbidity is deemed to be low.The decision about whether rt should be offered in conjunction with surgery should be made by clinicians and patients after weighing the potential benefit of improved local control against the potential harms and toxicity associated with rt.Depending on individual patient preferences, systemic therapy alone or rt alone might also be reasonable treatment options, regardless of whether the desmoid umours are deemed to be resectable. RECOMMENDATIONS FOLLOW-UP STRATEGIES: Undergo evaluation for rehabilitation (occupational therapy or physical therapy, or both).Continue with rehabilitation until maximal function is achieved.Undergo history and physical examinations with appropriate imaging every 3-6 months for 2-3 years, and then annually.

Entities:  

Keywords:  Clinical practice guideline; desmoid tumours; follow-up; treatment

Year:  2014        PMID: 25089635      PMCID: PMC4117629          DOI: 10.3747/co.21.2112

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  52 in total

1.  Extraabdominal desmoid tumor. A study of 83 cases.

Authors:  G Pignatti; G Barbanti-Bròdano; D Ferrari; F Gherlinzoni; F Bertoni; P Bacchini; E Barbieri; A Giunti; M Campanacci
Journal:  Clin Orthop Relat Res       Date:  2000-06       Impact factor: 4.176

2.  Extremity and trunk desmoid tumors: a multifactorial analysis of outcome.

Authors:  N B Merchant; J J Lewis; J M Woodruff; D H Leung; M F Brennan
Journal:  Cancer       Date:  1999-11-15       Impact factor: 6.860

3.  Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis.

Authors:  A Azzarelli; A Gronchi; R Bertulli; J D Tesoro; D Baratti; E Pennacchioli; P Dileo; A Rasponi; A Ferrari; S Pilotti; P G Casali
Journal:  Cancer       Date:  2001-09-01       Impact factor: 6.860

4.  Long-term outcomes for desmoid tumors treated with radiation therapy.

Authors:  B Ashleigh Guadagnolo; Gunar K Zagars; Matthew T Ballo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-02-20       Impact factor: 7.038

5.  Radiation therapy in the treatment of desmoid tumours reduces surgical indications.

Authors:  H A Rüdiger; S Y K Ngan; M Ng; G J Powell; P F M Choong
Journal:  Eur J Surg Oncol       Date:  2009-08-13       Impact factor: 4.424

6.  Preoperative radiotherapy is effective in the treatment of fibromatosis.

Authors:  F J O'Dea; J Wunder; R S Bell; A M Griffin; C Catton; B O'Sullivan
Journal:  Clin Orthop Relat Res       Date:  2003-10       Impact factor: 4.176

7.  The management of extra-abdominal desmoid tumours.

Authors:  Amit Duggal; Ian C Dickinson; Scott Sommerville; Price Gallie
Journal:  Int Orthop       Date:  2004-05-28       Impact factor: 3.075

8.  Local control of extra-abdominal desmoid tumors: systematic review and meta-analysis.

Authors:  Thomas J Wood; Kathleen M Quinn; Forough Farrokhyar; Ben Deheshi; Tom Corbett; Michelle A Ghert
Journal:  Rare Tumors       Date:  2013-02-11

9.  The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer Network.

Authors:  Brigitta G Baumert; Martin O Spahr; Arthur Von Hochstetter; Sylvie Beauvois; Christine Landmann; Katrin Fridrich; Salvador Villà; Michael J Kirschner; Guy Storme; Peter Thum; Hans K Streuli; Norbert Lombriser; Robert Maurer; Gerhard Ries; Ernst-Arnold Bleher; Alfred Willi; Juerg Allemann; Ulrich Buehler; Hugo Blessing; Urs M Luetolf; J Bernard Davis; Burkhardt Seifert; Manfred Infanger
Journal:  Radiat Oncol       Date:  2007-03-07       Impact factor: 3.481

10.  Transition of treatment for patients with extra-abdominal desmoid tumors: nagoya university modality.

Authors:  Yoshihiro Nishida; Satoshi Tsukushi; Yoji Shido; Hiroshi Urakawa; Eisuke Arai; Naoki Ishiguro
Journal:  Cancers (Basel)       Date:  2012-02-07       Impact factor: 6.639

View more
  8 in total

1.  Desmoid Tumours in Familial Adenomatous Polyposis: Review of 17 Patients from a Portuguese Tertiary Center.

Authors:  Marco Santos; Anabela Rocha; Vilma Martins; Marisa Santos
Journal:  J Clin Diagn Res       Date:  2016-10-01

2.  The Challenge in the Management of Extremity Fibromatoses: Our Experience.

Authors:  Mohanaraj Natarajan; Anand Raja; Vishnu Ramanujan
Journal:  Indian J Surg Oncol       Date:  2018-12-13

3.  Aggressive mutation in a familial adenomatous polyposis syndrome family: when phenotype guides clinical surveillance.

Authors:  Florencia Neffa; Lucia Garcia; Adriana Della Valle; Florencia Carusso; Carolina Vergara; Daniel Sanchez; Marta Sapone; Noelia Silveyra; Ana Laura Revello; Patricia Esperon
Journal:  J Gastrointest Oncol       Date:  2018-06

4.  Aggressive fibromatosis of the right colon mimicking a gastrointestinal stromal tumour: a case report.

Authors:  Milica Mitrovic Jovanovic; Aleksandra Djuric-Stefanovic; Dejan Velickovic; Ebrahimi Keramatollah; Marijan Micev; Aleksandra Jankovic; Stefan Milosevic; Jelena D Kovac
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

5.  Management strategies in Lynch syndrome and familial adenomatous polyposis: a national healthcare survey in Japan.

Authors:  Tomoki Yamano; Michiko Hamanaka; Akihito Babaya; Kei Kimura; Masayoshi Kobayashi; Miki Fukumoto; Kiyoshi Tsukamoto; Masafumi Noda; Nagahide Matsubara; Naohiro Tomita; Kenichi Sugihara
Journal:  Cancer Sci       Date:  2017-02       Impact factor: 6.716

6.  Outcome of surgery for primary and recurrent desmoid-type fibromatosis. A retrospective case series of 174 patients.

Authors:  Panagiotis Tsagozis; Jonathan Daniel Stevenson; Robert Grimer; Simon Carter
Journal:  Ann Med Surg (Lond)       Date:  2017-03-22

7.  Efficacy and safety of cyclooxygenase 2 inhibitors for desmoid tumor management: a systematic review.

Authors:  Makoto Emori; Yoshihiro Matsumoto; Yasutaka Murahashi; Masahiro Yoshida; Yoshihiro Nishida
Journal:  Nagoya J Med Sci       Date:  2021-11       Impact factor: 1.131

8.  The initiation, design, and establishment of the Desmoid Tumor Research Foundation Patient Registry and Natural History Study.

Authors:  Kelly A Mercier; Darragh M Walsh
Journal:  Rare Tumors       Date:  2019-10-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.